Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001654954-18-012674
Filing Date
2018-11-14
Accepted
2018-11-14 13:29:35
Documents
1
Period of Report
2018-09-30
Effectiveness Date
2018-11-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT sbfm_nt.htm NT 10-Q 37602
  Complete submission text file 0001654954-18-012674.txt   38933
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 181182352
SIC: 8731 Services-Commercial Physical & Biological Research